Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell-lung cancer

• SAITO Y.

収録刊行物

• Cancer Chemother Pharmacol

  Cancer Chemother Pharmacol 31 81-84, 1992

詳細情報

• CRID: 1572824501548958080
• NII論文ID: 80006873449
• NII書誌ID: AA00598397
• データソース種別:
  • CiNii Articles